- •SCORE periodical calibration is needed in countries with changing CVD epidemiology.
- •SCORE charts can also identify individuals at increased risk of cancer.
- •Rigorous cancer screening may be considered in individuals with SCORE ≥5%.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Internal Medicine
- Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017.The Lancet. 2018; 392: 1736-1788
- 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.Atherosclerosis. 2019; 290: 140-205
- 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).European Heart J. 2016; 37: 2315-2381
- Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.Eur Heart J. 2003; 24: 987-1003
- Longitudinal trends in cardiovascular mortality and blood pressure levels, prevalence, awareness, treatment, and control of hypertension in the Czech population from 1985 to 2007/2008.J Hypertens. 2010; 28: 2196-2203
- Explaining the decline in coronary heart disease mortality in the Czech Republic between 1985 and 2007.Eur J Prev Cardiol. 2012; 21: 829-839
- Shared Risk Factors for Cardiovascular Disease and Cancer: implications for Preventive Health and Clinical Care in Oncology Patients.Can J Cardiol. 2016; 32: 900-907
- Synergistic Opportunities in the Interplay Between Cancer Screening and Cardiovascular Disease Risk Assessment.Circulation. 2018; 138: 727-734
- Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8.Czech MONICA and Czech post-MONICA. Atherosclerosis. 2010; 211: 676-681
- Assessing the performance of prediction models: a framework for traditional and novel measures.Epidemiology. 2010; 21: 128-138
- Calibration Belt for Quality-of-Care Assessment Based on Dichotomous Outcomes.PLoS ONE. 2011; 6: e16110
- Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies.Eur Heart J. 2019; 40: 621-631
SinghJ.B.A. Expert Review: shared modifiable risk factors between cancer and CVD Am Coll Cardiol. 2017;http://www.acc.org/latest-in-cardiology/articles/2017/04/26/08/01/shared-modifiable-riskfactors-between-cancer-and-cvd.
- Cardiovascular disease and cancer: evidence for shared disease pathways and pharmacologic prevention.Atherosclerosis. 2017; 263: 343-351
KreatsoulasC., AnandS.S., SubramanianS.V. An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer. 2014;275(5):494–505.
- Association Between a 20-Year Cardiovascular Disease Risk Score Based on Modifiable Lifestyles and Total and Cause-Specific Mortality Among US Men and Women.J Am Heart Assoc. 2018; 7e010052
- Combined impact of lifestyle factors on mortality: prospective cohort study in US women.BMJ. 2008; 337: a1440
- The impact of a Mediterranean diet and healthy lifestyle on premature mortality in men and women.Am J Clin Nutr. 2011; 94: 913-920